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Abstract
Background:  Antimicrobial usage is considered the most important factor promoting the
emergence, selection and dissemination of antimicrobial-resistant microorganisms in both
veterinary and human medicine. The aim of this study was to investigate the prevalence and genetic
basis of tetracycline resistance in faecal Escherichia coli isolates from healthy broiler chickens and
compare these data with isolates obtained from hospitalized patients in Jamaica.
Results: Eighty-two E. coli strains isolated from faecal samples of broiler chickens and urine and
wound specimens of hospitalized patients were analyzed by agar disc diffusion to determine their
susceptibility patterns to 11 antimicrobial agents. Tetracycline resistance determinants were
investigated by plasmid profiling, transformations, and amplification of plasmid-borne resistance
genes. Tetracycline resistance occurred at a frequency of 82.4% in avian isolates compared to 43.8%
in human isolates. In addition, among avian isolates there was a trend towards higher resistance
frequencies to kanamycin and nalidixic acid (p < 0.05), while a greater percentage of human isolates
were resistant to chloramphenicol and gentamicin (p < 0.05). Multiple drug resistance was found
in isolates from both sources and was usually associated with tetracycline resistance. Tetracycline-
resistant isolates from both avian and human sources contained one or several plasmids, which
were transmissible by transformation of chemically-competent E. coli. Tetracycline resistance was
mediated by efflux genes tetB and/or tetD.
Conclusion: The present study highlights the prevalence of multiple drug resistant E. coli among
healthy broiler chickens in Jamaica, possibly associated with expression of tetracycline resistance.
While there did not appear to be a common source for multiple drug resistance in the strains from
avian or human origin, the genes encoding resistance are similar. These results suggest that genes
are disseminated in the environment and warrant further investigation of the possibility for avian
sources acting as reservoirs for tetracycline resistance.
Background
Antibiotic usage is possibly the most important factor that
promotes the emergence, selection and dissemination of
antibiotic-resistant microorganisms in both veterinary
and human medicine [1,2]. This acquired resistance
occurs not only in pathogenic bacteria but also in the
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endogenous flora of exposed individuals (animals and
humans) or populations [3-6]. In intensively reared food
animals, antibiotics may be administered to whole flocks
rather than individual animals, and antimicrobial agents
may be continuously fed to food animals such as broilers
and turkeys as antimicrobial growth promoters. Therefore
the antibiotic selection pressure for resistance in bacteria
in poultry is high and consequently their faecal flora con-
tains a relatively high proportion of resistant bacteria [7].
In Jamaica, chicken is considered to be the most widely
produced and consumed meat protein, five times more
than beef and 10 times more than pork. Over the period
1998 – 2002, Jamaica's local poultry production yielded
approximately 380 M kg with a monetary value of nearly
$90 billion [8]. Chicken farms are widely distributed
throughout the island with the majority being located on
the south coast and large commercial operations account-
ing for 65–70% of total broiler production [8]. Thus, the
high consumption of chicken meat warrants great care in
safeguarding the industry against threatening factors.
At slaughter, resistant strains from the gut may contami-
nate poultry carcasses and as a result poultry meats are
often associated with multiresistant E. coli [9-11]; likewise
eggs become contaminated during laying [12]. Hence,
antimicrobial resistant faecal E. coli from poultry can
infect humans both directly and via food. Although rare,
these resistant bacteria may colonize the human intestinal
tract and may also contribute resistance genes to human
endogenous flora.
However, the mechanism of spread of antibiotic resist-
ance from food animals to humans remains controversial.
Colonization of the intestinal tract with resistant E. coli
from chicken has been shown in human volunteers [13]
and there is historical evidence that animals are a reservoir
for E. coli found in humans [14]. Further, spread of anti-
biotic resistance plasmids in E. coli from chickens to
human handlers [15,16] or of antibiotic-resistant micro-
organisms from poultry to humans in various countries
[13,17-19] has been reported. Resistance has been found
in organisms common to both humans and animals, such
as  Salmonella  spp.,  Campylobacter  spp. and enterococci
among others [20]. Due to the intricate balance of micro-
flora of different habitats within the ecosystem, the trans-
fer of resistance genes among bacteria occupying different
habitats has the potential to occur frequently. Resistance
genes may be transferred vertically among bacteria of dif-
ferent genera and families [21] or horizontally among dif-
ferent bacterial species within the same genus or family
[22,23].
Table 1: Percentages of E. coli isolates from avian and human sources susceptible (S), intermediate (I) and resistant (R) to 
antimicrobial agents by NCCLS disc diffusion methods.
Antimicrobial agent (µg) Diffusion zone 
breakpoint 
(mm)
Avian isolates (n = 34) Human isolates (n = 48)
SIRSIR
Aminoglycosides
Gentamicin (10) ≤ 12 100 0 0 60.4 6.3 33.3
Kanamycin (30) ≤ 13 2.9 5.9 91.2 8.3 18.8 43.8
β-lactams
Ampicillin (10) ≤ 13 73.5 5.9 20.6 58.3 6.3 35.4
Amoxicillin/clavulanate (20) ≤ 13 85.3 11.8 2.9 79.2 18.8 2.1
Phenicols
Chloramphenicol (30) ≤ 12 88.2 8.8 2.9 68.8 6.3 25
Quinolones
Ciprofloxacin (5) ≤ 15 64.7 26.5 8.8 89.6 0 10.4
Enrofloxacin (5) ≤ 17 32.4 38.2 29.4 89.6 0 10.4
Nalidixic acid (30) ≤ 13 11.8 2.9 85.3 89.6 0 10.4
Norfloxacin (5) ≤ 12 64.7 14.7 20.6 91.7 2.1 6.3
Ofloxacin (5) ≤ 12 85.3 2.9 11.8 91.7 0 8.3
Tetracyclines
Tetracycline (30) ≤ 14 17.6 0 82.4 39.6 16.7 43.8BMC Veterinary Research 2006, 2:7 http://www.biomedcentral.com/1746-6148/2/7
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Molecular tools have been used to correlate animal asso-
ciated pathogens with similar pathogens affecting
humans and to clearly demonstrate transferable resistant
genes carried by plasmids common to both animals and
humans [2,21,24,25]. The possibility for transfer of anti-
biotic resistance genes among humans, animals and the
environment [22] is a direct threat to public health. This
threat prompts ongoing research into emerging resistance
mechanisms, novel approaches to antimicrobial efficacy
and stringent control measures in the prudent use of anti-
microbials in animal and human medicine. As the possi-
bility of transfer of tetracycline-resistant bacteria from
animals to humans is controversial, tetracycline-resistant
E. coli isolates from poultry and humans sources were ana-
lysed for plasmid diversity and the presence of specific
genes associated with tetracycline resistance.
The aim of this study was to investigate the prevalence and
genetic basis of tetracycline resistance in commensal E.
coli  strains isolated from healthy broiler chickens and
compare these data with isolates obtained from hospital-
ized patients.
Results
Antimicrobial susceptibility
A total of 82 isolates of E. coli were analysed, 34 from
broiler chickens and 48 from humans. The percentage of
isolates susceptible, intermediate and resistant to each
antimicrobial agent is outlined in Table 1. There was a
trend towards higher resistance frequency among avian
isolates, especially to kanamycin, nalidixic acid and tetra-
cycline (p < 0.05). However, a greater percentage of
human isolates were resistant to chloramphenicol and
gentamicin (p < 0.05). All avian isolates were susceptible
to gentamicin, and there was no significant difference
between resistance rates for the β-lactams and the fluoro-
quinolones for avian and human isolates. No tetracycline-
resistant E. coli isolate was recovered from feed and water
samples from any of the five farms.
Of the aminoglycosides included in the panel, the suscep-
tibility results were varied with 91.2% and 0% of avian E.
coli isolates expressing resistance to kanamycin and gen-
tamicin respectively. Avian E. coli expressed resistance to
the β-lactams, ampicillin and amoxicillin/clavulanic acid
at frequencies of 20.6% and 2.9% respectively. Tetracy-
cline resistance occurred at a frequency of 82.4%. Among
the fluoroquinolones, ciprofloxacin, enrofloxacin, nor-
floxacin and ofloxacin, resistance expressed by the isolates
were relatively similar at 11.8%, 29.4%, 20.6% and 14.7%
respectively. Among the avian E. coli isolates, frequency of
resistance to the first generation quinolone nalidixic acid
was approximately four-fold greater when compared with
the fluoroquinolones. This difference was statistically sig-
nificant (p < 0.05).
Most of the human E. coli isolates were susceptible to the
antimicrobial agents used in the study; and 43.8% and
33.3% showed resistance to the aminoglycosides, kan-
amycin and gentamicin, respectively, and 43.8% were
resistant to tetracycline. An expected difference was
observed in the resistance pattern of these isolates to the
Table 2: Prevalence of multiple resistant patterns in avian and human E. coli isolates
Number of 
antimicrobials 
resistant
Avian isolates (n = 34) Human isolates (n = 48)
Antimicrobial resistance pattern (ARP) ARP 
frequency
Antimicrobial resistance pattern (ARP) ARP 
frequency
0- 0 - 1 3
1 Km; Nal 1;1 Km; Tet; Gen 5;1;1
2 Km-Amp; Km-Nal; Km-Tet; Nal-Tet 3;1;1;1 Km-Gen; Km-Cm; Km-Tet 4;1;1
3 Km-Nal-Tet 14 Km-Gen-Cm; Km-Tet-Amp; Km-Gen-Ofx; Tet-
Cm-Amp; Km-Gen-Tet
2;4;1;1;1
4 Km-Nal-Tet-Enr; Km-AMC-Nal-Tet; 4;1 Km-Gen-Tet-Amp; Km-Tet-Cm-Amp 3;3
5 Km-Nal-Tet-Nor-Enr; Km-Nal-Tet-Amp-Nor 1;1 Km-Tet-Cm-Amp-AMC 1
6 Km-Nal-Tet-Ofx-Nor-Enr 1 - 0
7 Km-Nal-Tet-Ofx-Nor-Cip-Enr; Nal-Amp-Tet-Ofx-
Nor-Cip-Enr
1;1 Km-Gen-Nal-Tet-Enr-Cm-Amp; Km-Gen-Tet-Cip-
Enr-Amp-Cm; Km-Tet-Cip-Enr-Nor-Ofx-Amp; 
Km-Gen-Nal-Tet-Cip-Cm-Amp; Km-Nal-Tet-Ofx-
Nor-Cip-Amp
1;1;1;1;1
8 Km-Nal-Amp-Tet-Ofx-Nor-Cip-Enr 1 Km-Nal-Tet-Cip-Enr-Nor-Ofx-Cm 1
≥9 Km-Nal-Tet-Amp-Ofx-Nor-Cip-Enr-Cm 1 Km-Gen-Amp-Nal-Tet-Cip-Enr-Nor-Ofx 1
Key: Km = kanamycin; Gen = gentamicin; Nal = nalidixic acid; Amp = ampicillin; Tet = tetracycline; AMC = amoxicillin/clavulanate; Cip = 
ciprofloxacin; Enr = enrofloxacin; Nor = norfloxacin; Ofx = ofloxacin; Cm = chloramphenicolBMC Veterinary Research 2006, 2:7 http://www.biomedcentral.com/1746-6148/2/7
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β-lactams, ampicillin (35.4%) and amoxicillin/clavulanic
acid (2.1%). There was a similar low level of resistance to
the quinolone family (≤ 10.4%).
The prevalence of multiple resistance patterns in avian
and human E. coli isolates is given in Table 2. The resist-
ance pattern most frequently observed in avian isolates
was resistance to kanamycin in combination with nalid-
ixic acid and tetracycline (41.2%). This resistance pattern
was observed in avian isolates resistant to four or more
antimicrobials and human isolates resistant to seven or
more antimicrobials. The next most frequent resistance
phenotypes were resistance to kanamycin, nalidixic acid,
tetracycline and enrofloxacin at 11.8%, and kanamycin
and ampicillin at 8.8%. The remaining 13 avian E. coli iso-
lates exhibited a single unique phenotypic pattern and of
this, 23% were resistant to 2 antimicrobials, 15.4% were
resistant to one antibiotic and 61.5% exhibited unique
multiple resistance pattern to ≥ 4 antimicrobials (Table 2;
Figure 1). Multi-drug resistance was defined as resistance
exhibited to three or more antimicrobials.
Among the human E. coli isolates, 72.9% expressed resist-
ance to one or more antimicrobials and 18.8% were resist-
ant to three antimicrobials (Table 2; Figure 1).
Approximately 15% of human isolates showed resistance
to a single antibiotic (kanamycin, tetracycline or gen-
tamicin), and resistance to two and four antibiotics
occurred at a frequency of 12.5% each. Resistance to five
or more antibiotics occurred at frequencies of less than
7%.
Isolates that were resistant to other agents were examined
for their susceptibilities to tetracycline (Table 3), and iso-
lates resistant to tetracycline were examined for their sus-
ceptibilities to other agents (Table 4). Cross-resistance to
the various classes of antimicrobials was observed, how-
ever, most of these isolates were resistant to tetracycline.
Notable exceptions were the ampicillin-resistant avian
isolates and the kanamycin-resistant human isolates, of
which 42.9% and 37.5%, respectively, were susceptible to
tetracycline (Table 3). On the other hand, between 10.4
and 42.4% of tetracycline-resistant (Tet-R) avian isolates
were resistant to the fluoroquinolones, in particular enro-
floxacin, with almost all being resistant to nalidixic acid
and kanamycin (Table 4). Most (96.4%) of the Tet-R
human isolates were resistant to ampicillin and kanamy-
cin, followed by chloramphenicol (42.9%), gentamicin
(38.1%) and the fluoroquinolones (14.3–23.8%).
Although not statistically significant, it was interesting to
note that a greater percentage of human isolates were
resistant to enrofloxacin.
Prevalence of multiple antimicrobial resistance in avian and  human E. coli isolates Figure 1
Prevalence of multiple antimicrobial resistance in avian and 
human E. coli isolates.
Table 3: Tetracycline susceptibilities of isolates resistant to other antimicrobials
Agent to which isolate was 
resistant
Avian isolates (n = 34) Human isolates (n = 48)
No. of isolates Isolates susceptible to 
tetracycline (%)
No. of isolates Isolates susceptible to 
tetracycline (%)
Ampicillin 7 3 (42.9)* 17 0 (0.0)
Amoxicillin/clavulanate 1 0 (0.0) 1 0 (0.0)
Chloramphenicol 1 0 (0.0)* 12 3 (25.0)
Ciprofloxacin 4 0 (0.0) 5 0 (0.0)
Enrofloxacin 10 0 (0.0) 5 0 (0.0)
Gentamicin 0 0 16 0 (0.0)
Kanamycin 31 5 (16.1)* 32 12 (37.5)
Nalidixic acid 29 2 (6.9)* 5 0 (0.0)
Norfloxacin 7 0 (0.0) 3 0 (0.0)
Ofloxacin 5 0 (0.0)* 4 1 (25.0)
* p < 0.05 vs. human isolatesBMC Veterinary Research 2006, 2:7 http://www.biomedcentral.com/1746-6148/2/7
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Plasmid profiling and transformations
One or more plasmid bands between 2 kb and ≥ 12 kb
were observed in all but seven avian and eight human tet-
racycline-resistant isolates (Figure 2). Defining different
profiles as ones differing in at least one plasmid band, six
plasmid profiles were observed among the avian isolates
and three plasmid profiles were observed among the
human isolates.
Purified plasmids from tetracycline resistant isolates were
used to transform chemically-competent E. coli JM109
(DE3) (Promega), however only the 12 kb plasmid was
recovered from transformants. Transformants had similar
antimicrobial susceptibilities to donor strains (data not
shown).
Digestion of these 12-kb plasmids with EcoR1, BamH1
and  Hind111, did not reveal any significant polymor-
phisms (data not shown).
Tetracycline-resistance genes
Tetracycline-resistance genes of E. coli strains expressing
tetracycline resistance were amplified in PCR with primers
targeting tetracycline efflux genes tetB and/or tetD. PCR
products were obtained for all 21 Tet-R avian and 13
human isolates (Figure 3).
Discussion
In this study we examined antimicrobial resistance in
commensal E. coli isolates from broiler chickens and com-
pared them to clinical isolates from hospitalized patients.
Because of the geographic sampling of the avian isolates,
this surveillance provides a representative sample of the
resistance trends in the Jamaican poultry industry.
Compared with the other antimicrobial agents used in
this study, avian isolates were susceptible to gentamicin,
amoxicillin/clavulanate and chloramphenicol. However,
increasing resistance frequencies were noted for the fluor-
oquinolones, in the apparent absence of selection pres-
sure.
There is strong evidence that the use of antimicrobial
agents can lead to the emergence and dissemination of
resistant  E. coli [13,15,16,26-28], which can then be
passed onto people via food or through direct contact
with animals. However, there are increasing numbers of
reports detailing circulation and amplification of antimi-
crobial resistance genes, including tetracycline resistance
in the environment [22,30,29,31,32], which could facili-
tate the emergence and spread of antibiotic resistance in
bacteria. The finding of multiple drug resistant commen-
sal E. coli isolates from broiler chickens from farms that
did not report antibiotic use concurs with these latter
reports. Rysz and Alvarez [31] demonstrated that bacteria
in the soil could acquire resistance to tetracycline from
environmental exposure, possibly creating a reservoir of
resistance factors generated outside host animals. Their
finding suggests that collection of environmental samples
from a farm is important for accessing exposure to resist-
ance factors from farm runoff in watersheds, except in
cases where soil is augmented with organic fertilizer.
Sayah et al. [32] reported that farm environmental isolates
showed reduced susceptibility (as measured by disc diffu-
sion zone sizes) compared to faecal sample isolates to
most agents studied. They suggested that non-sampled
sources, e.g., farm workers and wildlife with access to the
farm environment, could be sources of resistance factors.
We concur with this as a possible source of resistance
determinants in our study.
Antimicrobial resistance to tetracycline, kanamycin and
nalidixic acid was noted among avian E. coli isolates
(Table 1). The presence and frequency of tetracycline
resistance in E. coli from chickens agree with findings of
other studies on antibiotic resistance in E. coli [16,32]. The
Table 4: Susceptibilities of tetracycline-resistant isolates to other antibiotics
Antimicrobial agent Isolates susceptible
Avian isolates (%) (n = 28) Human isolates (%) (n = 21)
Ampicillin 24 (85.7)* 4 (19.0)
Amoxicillin/clavulanate 27 (96.4) 20 (95.2)
Chloramphenicol 27 (96.4)* 12 (57.1)
Ciprofloxacin 25 (89.3) 16 (76.2)
Enrofloxacin 16 (57.6) 13 (61.9)
Gentamicin 28 (100.0)* 13 (61.9)
Kanamycin 1 (3.6) 2 (9.5)
Nalidixic acid 1 (3.6)* 16 (76.2)
Norfloxacin 21 (75.0) 18 (85.7)
Ofloxacin 24 (85.7) 18 (85.7)
*p < 0.05 vs. human isolatesBMC Veterinary Research 2006, 2:7 http://www.biomedcentral.com/1746-6148/2/7
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patterns of resistance to tetracycline have been attributed
in part to widespread and lengthy use of tetracycline in the
poultry industry [3,4,6,15,16]. Since tetracycline is a nat-
urally derived compound, bacteria can be exposed to
these agents in nature and outside any human use for dis-
ease treatment, for prophylaxis, or for livestock growth
promotion. Tetracycline is a commonly used first line
antibiotic for many domestic animals and is often used
before the antibiotic resistance profile of a pathogen has
been determined. Resistance to tetracycline is plasmid
mediated, with a wide variety of genetic determinants
[33]. This makes it more possible for a susceptible bacte-
rium to acquire resistance factors by conjugation, or by
transformation, as was demonstrated in this study.
Low levels of resistance were observed for ofloxacin, cip-
rofloxacin and gentamicin. The observation that over 85%
of avian E. coli isolates were resistant to nalidixic acid
(concomitant with reduced susceptibilities to the fluoro-
quinolones) is important considering that the fluoroqui-
nolones are used to treat a range of E. coli infections in
humans [34]. This finding concurs with previous reports
[16,35], and underscores the need to monitor quinolone-
and fluoroquinolone-resistant bacteria in poultry produc-
tion as their emergence is an important health concern
among most in the food safety community. This is against
the background that nalidixic acid selects for low-level
resistance to ciprofloxacin (and possibly other fluoroqui-
nolones) [36]. While quinolone resistance involves chro-
mosomal mutations that reduce membrane permeability
and decrease drug accumulation or alter DNA topoi-
somerases, resistance to fluoroquinolones is most associ-
ated with mutations in DNA gyrase [36,37].
Aminoglycoside resistance in E. coli most often occurs by
aminoglycoside-modifying enzymes [38,39] encoded on
transmissible plasmids [40]. It is not surprising that more
isolates were resistant to kanamycin when compared to
gentamicin, as kanamycin is susceptible to the largest
number of enzymes. Conversely, resistance to gentamicin
is mediated by modifications at few sites on the molecule.
Multi-drug resistance (to at least three antimicrobials) was
found in E. coli from both avian and human sources
(Table 2; Fig. 1), but was higher in frequency and propor-
tion in avian isolates. However, when these multi-drug
resistant organisms were compared, it is clear that they do
not have common sources of resistant bacteria. Most
avian multi-drug resistant isolates exhibited resistance to
a combination of antimicrobials that included kanamy-
cin, tetracycline and nalidixic acid, while most human iso-
lates were resistant to kanamycin and tetracycline or
kanamycin and gentamicin. This suggests that avian iso-
lates that were Tet-R are more likely to become resistant to
additional antimicrobial agents. Resistance to tetracycline
may be conserved in bacterial populations over time,
regardless of selection pressure, which might result in an
overall increase in resistance over time. In addition, it is
likely that avian sources could act as reservoirs for Tet-R
for environmental contamination and human coloniza-
tion. Further, the difference in resistance between the two
groups of isolates can be explained in terms of the interac-
tions of the organisms (associated with the host) and
potential horizontal gene transfer in their respective envi-
ronments.
PCR products of tetracycline resistance determinants B and  D from tetracycline resistant avian and human E. coli isolates Figure 3
PCR products of tetracycline resistance determinants B and 
D from tetracycline resistant avian and human E. coli isolates. 
Lane 1, 1 kb ladder; Lane 2, A13; Lane 3, A16; Lane 4, A19; 
Lane 5, A20; Lane 6, A20T; Lane 7, H60; Lane 8, H62; Lane 9, 
H71; Lane 10, H97.
Gel electrophoresis of plasmids isolated from avian and  human E. coli isolates Figure 2
Gel electrophoresis of plasmids isolated from avian and 
human E. coli isolates. Lanes 1, A7, Lane 2, A17, Lane 3, A28, 
Lane 4, A30, Lane 5, H57, Lane 6, H60, Lanes 7, H61; Lane 8, 
H78; Lanes 9 and 10, blank; Lane 11, Plasmid markers, 
pUC4K (3.9 kb), pTYB11 (7.4 kb) and pHS1 (12 kb).BMC Veterinary Research 2006, 2:7 http://www.biomedcentral.com/1746-6148/2/7
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To deal with multi-drug resistant organisms, it is usually
recommended that potentially synergistic antimicrobial
combinations be used. We evaluated our isolates for
cross-resistance between tetracycline and other agents.
Isolates resistant to other antimicrobial agents, except
ampicillin, were also resistant to tetracycline. Tetracycline-
resistant strains from avian sources were susceptible to
ampicillin, amoxicillin/clavulanate, chloramphenicol,
ciprofloxacin and gentamicin, but resistant to kanamycin
and nalidixic acid. This indicates limited cross-resistance
and suggests that potential therapeutic options still exist
for poultry colonized by Tet-R E. coli. On the other hand,
a greater percentage of the Tet-R strains from human
sources were resistant to other antibiotics, although 57 –
95% was susceptible to amoxicillin/clavulanate, gen-
tamicin and the quinolones. Among these isolates, there
was significant cross-resistance to the aminoglycosides,
ampicillin, and the quinolones.
Our results indicate that the Tet-R plasmids carried by
avian or human E. coli isolates demonstrate the distribu-
tion of similar resistance determinants in diverse genetic
backgrounds. This probably indicates a low level of expo-
sure as animal hosts with a continuous exposure to tetra-
cycline have a higher percentage of Tet-R E. coli, and these
isolates carry a greater diversity of resistance genes.
In gram negative organisms, including E. coli, tetracycline
resistance is frequently regulated by efflux genes that are
normally associated with large plasmids which are mostly
conjugative. These plasmids often carry other antibiotic
resistance genes, heavy metal resistance genes and/or
other pathogenic factors such as toxins, hence the selec-
tion for any of these factors selects for the plasmid. The
molecular investigations into the underlying tetracycline
resistance mechanisms revealed that 69% of the tetracy-
cline-resistant isolates possessed resistance plasmids
based on successful transformations of a susceptible
strain. It is likely that the remainder of isolates were using
resistance mechanisms based on the chromosome or on
integrons carried on plasmids [41,42]. A mechanism for
tetracycline resistance was investigated using universal
primer pairs based on sequences belonging to the efflux
classes,  tetB  and  tetD  [30]. The resulting products of
approximately 1 kb would strongly suggest that tetracy-
cline resistance among the E. coli isolates in this study is
regulated mainly by genes encoding an efflux pump
mechanism. These Tet-R strains contained either tetB or
tetD efflux genes, which together with the absence of pol-
ymorphism in the plasmid RFLP data, suggest that there is
a similarity of tetracycline resistance mechanism in these
organisms. Since many human and poultry commensal
bacteria carry the same tet genes, plasmids, transposons
and integrons as disease-causing species [43], our results
suggest that these agents could be transferred to disease-
causing bacteria.
Conclusion
In conclusion, the results of this study provide evidence
for significant antimicrobial resistance of E. coli isolates
from broiler chickens raised on farms without recorded
antimicrobial use, and hospitalized patients in Jamaica.
We noted that tetracycline resistance was generally associ-
ated with plasmids, and the resistance was mediated by
tetB or tetD efflux genes. The results suggest that tetracy-
cline resistance mechanisms from avian and human
sources may be similar. Long-term prospective studies
examining isolates from defined geographic locations are
required to more accurately detect temporal and spatial
differences in antimicrobial resistance in strains of E. coli.
Methods
Avian and human E. coli isolates
Fresh faecal samples were collected randomly from five
poultry farms (approximately 4 km apart) in the parish of
St. Catherine, Jamaica between 2000 and 2001. Samples
(100 g) were collected over a 42-day period at 3-day inter-
vals, kept at 6°C and bacteriological analyses were per-
formed within 4 h of collection. The flocks investigated, as
well as other flocks on the farms consisting of older birds,
were not treated with antibiotics during the period of
investigation. Farm records indicated that no antimicro-
bial agents were administered during the 12 months prior
to sample collection. Feed and water samples were sam-
pled at each visit to the different farms and screened for E.
coli resistant to tetracycline. Domestic animals were either
absent or located at least 500 m from the broiler opera-
tions.
Forty-eight clinical isolates of E. coli isolated from urine
and wound specimens from hospitalized patients at the
University Hospital of the West Indies, St. Andrew,
Jamaica during 1999, were also analysed in this study. The
University Hospital is a 500-bed, multi-disciplinary teach-
ing hospital that is attached to the Faulty of Medical Sci-
ences at the University of the West Indies in Jamaica. The
hospital serves the metropolitan area of Kingston and St.
Andrew, and is located about 80 km from the nearest
broiler farm that was investigated.
All E. coli organisms were isolated and purified on MacCo-
nkey agar (Difco laboratories, Detroit, Mich.) and inocu-
lated onto Triple-iron agar, urea agar, Simmons' citrate
agar and Motility-indole-lysine media (Difco). Isolates
yielding similar biochemical reactions to the standard E.
coli  strain, ATCC 25922 were identified as E. coli and
selected for further testing. These E. coli isolates were
transferred to 2 ml Luria broth and incubated 37°C for
18–24 h. One millilitre (1 ml) of this culture was addedBMC Veterinary Research 2006, 2:7 http://www.biomedcentral.com/1746-6148/2/7
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to 0.8 ml of sterile 80% glycerol in a sterile tube, vortexed
and stored at -80°C.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests were performed by the
standard disc diffusion technique in accordance with the
recommendations of the National Committee for Clinical
Laboratory Standards (NCCLS) [44]. Antibiotics used in
this study are given in Table 1. Cartridges of antimicro-
bial-containing discs were obtained from Oxoid (Hamp-
shire, UK), Mast Diagnostics (Merseyside, UK), BBL
(Becton Dickinson, Cockeysville, MD) or Janssen-Cilag
(Puebla, Mexico), stored between 4 and -20°C, and
allowed to come to room temperature prior to use. Iso-
lates were subcultured from the bank onto Miller's LB agar
and incubated for 18–24 h before being transferred to 5
ml sterile 0.9% saline to match the '0.5' MacFarland
standard (Remel, Kansas). A sterile cotton-tipped swab
was used to streak air-dried Mueller-Hinton II plates
within 15 min of adjustment of turbidity. Subsequently,
antimicrobial discs were added and plates were incubated
aerobically at 35 ± 2°C for 16–18 h. The diameter of the
zones of inhibition surrounding the antimicrobial discs
was measured to the nearest mm. Isolates were deemed
resistant only when the zone of inhibition was less than or
equal to the resistance breakpoint recommended by the
NCCLS guidelines [44]. Quality control was performed as
recommended using E. coli strain ATCC 25922.
Plasmid profiling and transformations
All isolates resistant to tetracycline (NCCLS interpretive
zone ≤ 14 mm) were screened for plasmid content accord-
ing to the alkaline-lysis mini prep method [45] and
resolved on 0.7% agarose gels. Plasmid DNA used as size
markers were kind gifts of Dr. S. Morrison. Plasmids were
purified from gels and used to transform tetracycline-sen-
sitive chemically-competent E. coli JM 109(DE3)
(Promega), according to the supplier's instructions. Trans-
formants were analysed on selective media containing 30
or 60 µg/ml tetracycline (Sigma) after incubation at 37°C
for 18–24 h. The plasmid-free host strain was included as
a susceptible control.
Restriction fragment length polymorphism (RFLP)
To determine the degree of genetic similarity between
resistance plasmids, the 12 kb plasmids were digested
with BamH1, EcoRI and HindIII (Promega) according to
the manufacturer's instructions. Banding patterns were
compared based on visual inspection of the ethidium bro-
mide-stained gels.
Identification of Tet-R genes
Tetracycline efflux genes (tetB and tetD) were amplified by
PCR with the primers tetBD-F and tetBD-R [30]. The pre-
dicted sizes of the PCR-amplified products were 967 or
964 bp for the tetB or tetD product, respectively. Amplifi-
cation reactions were carried out in a 25 µl volume con-
taining 5 µl (5 ng/µl) plasmid DNA, 2.5 µl buffer ×10, 2
µl (25 mM) MgCl2, 5 µl (500 µM) dNTP mix, 0.25 µl (5
pmol/µl) of each primer, and 0.2 µl (5 U/µl) Taq polymer-
ase (Promega). DNA samples were denatured at 95°C for
5 min in a Perkin Elmer GeneAmp System 9600 (PE Bio-
systems, CA), and amplified by 30 cycles of 94°C for 60 s,
50°C for 45 s, and at 72°C for 90 s, with an additional
extension at 72°C for 300 s [30]. Products were separated
on 0.7% agarose in 0.5 × TBE and visualized by UV light
after staining with ethidium bromide.
Statistical analysis
The antimicrobial susceptibility data are expressed as per-
centages or frequency of the avian or human isolates. A
one-way analysis of variance or χ2 statistics was used to
estimate overall difference between the percentages or fre-
quencies of resistance between avian and human E. coli
isolates. In all cases, p < 0.05 was regarded as statistically
significant.
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